Andrea Caballero-Garralda
Overview
Explore the profile of Andrea Caballero-Garralda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
1166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Degenhardt F, Ellinghaus D, Juzenas S, Lerga-Jaso J, Wendorff M, Maya-Miles D, et al.
Hum Mol Genet
. 2022 Jul;
31(23):3945-3966.
PMID: 35848942
Given the highly variable clinical phenotype of Coronavirus disease 2019 (COVID-19), a deeper analysis of the host genetic contribution to severe COVID-19 is important to improve our understanding of underlying...
2.
Garcia-Garcia S, Caballero-Garralda A, Tabernero D, Cortese M, Gregori J, Rodriguez-Algarra F, et al.
Biomedicines
. 2022 May;
10(5).
PMID: 35625929
Deletions in the 3' end region of the hepatitis B virus (HBV) X open reading frame () may affect the core promoter (Cp) and have been frequently associated with hepatocellular...
3.
Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, et al.
N Engl J Med
. 2020 Jun;
383(16):1522-1534.
PMID: 32558485
Background: There is considerable variation in disease behavior among patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19). Genomewide association analysis...
4.
Lopez-Martinez R, Arias-Garcia A, Rodriguez-Algarra F, Castellote-Belles L, Rando-Segura A, Tarraso G, et al.
J Clin Microbiol
. 2019 Nov;
58(1).
PMID: 31694971
The remarkable effectivity of current antiviral therapies has led to consider the elimination of hepatitis C virus (HCV) infection. However, HCV infection is highly underdiagnosed; therefore, a global strategy for...